These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31554244)

  • 21. Increased brain hemopexin levels improve outcomes after intracerebral hemorrhage.
    Leclerc JL; Santiago-Moreno J; Dang A; Lampert AS; Cruz PE; Rosario AM; Golde TE; Doré S
    J Cereb Blood Flow Metab; 2018 Jun; 38(6):1032-1046. PubMed ID: 27864463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heme-hemopexin: a 'chronosteric' heme-protein.
    Ascenzi P; Fasano M
    IUBMB Life; 2007 Nov; 59(11):700-8. PubMed ID: 17968708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heme-mediated reactive oxygen species toxicity to retinal pigment epithelial cells is reduced by hemopexin.
    Hunt RC; Handy I; Smith A
    J Cell Physiol; 1996 Jul; 168(1):81-6. PubMed ID: 8647926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An investigation of hemopexin redox properties by spectroelectrochemistry: biological relevance for heme uptake.
    Flaherty MM; Rish KR; Smith A; Crumbliss AL
    Biometals; 2008 Jun; 21(3):239-48. PubMed ID: 17712531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemopexin reduces blood-brain barrier injury and protects synaptic plasticity in cerebral ischemic rats by promoting EPCs through the HO-1 pathway.
    Yang Y; Dong B; Lu J; Wang G; Yu Y
    Brain Res; 2018 Nov; 1699():177-185. PubMed ID: 30092232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reductive nitrosylation and peroxynitrite-mediated oxidation of heme-hemopexin.
    Ascenzi P; Bocedi A; Antonini G; Bolognesi M; Fasano M
    FEBS J; 2007 Jan; 274(2):551-62. PubMed ID: 17229156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.
    Vinchi F; Tolosano E
    Oxid Med Cell Longev; 2013; 2013():396527. PubMed ID: 23781294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemopexin in the human retina: protection of the retina against heme-mediated toxicity.
    Hunt RC; Hunt DM; Gaur N; Smith A
    J Cell Physiol; 1996 Jul; 168(1):71-80. PubMed ID: 8647924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When might transferrin, hemopexin or haptoglobin administration be of benefit following the transfusion of red blood cells?
    Buehler PW; Karnaukhova E
    Curr Opin Hematol; 2018 Nov; 25(6):452-458. PubMed ID: 30281034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two beta-propeller domains.
    Paoli M; Anderson BF; Baker HM; Morgan WT; Smith A; Baker EN
    Nat Struct Biol; 1999 Oct; 6(10):926-31. PubMed ID: 10504726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. O2-mediated oxidation of hemopexin-heme(II)-NO.
    Fasano M; Antonini G; Ascenzi P
    Biochem Biophys Res Commun; 2006 Jun; 345(2):704-12. PubMed ID: 16696943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity.
    Deuel JW; Vallelian F; Schaer CA; Puglia M; Buehler PW; Schaer DJ
    Free Radic Biol Med; 2015 Dec; 89():931-43. PubMed ID: 26475040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.
    Gram M; Anderson UD; Johansson ME; Edström-Hägerwall A; Larsson I; Jälmby M; Hansson SR; Åkerström B
    PLoS One; 2015; 10(9):e0138111. PubMed ID: 26368565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.
    Vercellotti GM; Zhang P; Nguyen J; Abdulla F; Chen C; Nguyen P; Nowotny C; Steer CJ; Smith A; Belcher JD
    Mol Med; 2016 Sep; 22():437-451. PubMed ID: 27451971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pro-Inflammatory Actions of Red Blood Cell-Derived DAMPs.
    Jeney V
    Exp Suppl; 2018; 108():211-233. PubMed ID: 30536173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane phospholipid reorganization differentially regulates metallothionein and heme oxygenase by heme-hemopexin.
    Escriba PV; Morales P; Smith A
    DNA Cell Biol; 2002 Apr; 21(4):355-64. PubMed ID: 12042074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of Plasma Protein Hemopexin Results in Increased Duodenal Iron Uptake.
    Fiorito V; Geninatti Crich S; Silengo L; Aime S; Altruda F; Tolosano E
    PLoS One; 2013; 8(6):e68146. PubMed ID: 23826373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.
    Vinchi F; Costa da Silva M; Ingoglia G; Petrillo S; Brinkman N; Zuercher A; Cerwenka A; Tolosano E; Muckenthaler MU
    Blood; 2016 Jan; 127(4):473-86. PubMed ID: 26675351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemolysis, free hemoglobin toxicity, and scavenger protein therapeutics.
    Vallelian F; Buehler PW; Schaer DJ
    Blood; 2022 Oct; 140(17):1837-1844. PubMed ID: 35660854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in Systemic Extracellular Heme and Hemopexin Are Associated With Adverse Clinical Outcomes in Ugandan Children With Severe Malaria.
    Elphinstone RE; Conroy AL; Hawkes M; Hermann L; Namasopo S; Warren HS; John CC; Liles WC; Kain KC
    J Infect Dis; 2016 Oct; 214(8):1268-75. PubMed ID: 27515862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.